₹23.04
-0.29 (-1.24%)
As of 18 Sept 2026, Balaxi Pharmaceuticals Ltd share price is ₹23.04. The stock opened at ₹23.04 and had closed at ₹23.33 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹15.20 and a high of ₹47.71. In terms of performance, Balaxi Pharmaceuticals Ltd share price has increased by 30.04% over the past six months and has decreased by 50.12% over the last year.
BALAXI Stock Price Chart
Balaxi Pharmaceuticals Ltd Overview
Market cap₹127 Crs
Volume24,054
Prev. Close₹23.33
Year range₹15.20 - ₹47.71
ISININE618N01022
About BALAXI
Balaxi Pharmaceuticals is engaged a Commenced the business of International Wholesale Trading of Pharmaceuticals.
Balaxi Pharmaceuticals Ltd Historical Performance
1 Month Return-3.63%
6 Month Return32.03%
3 Year Return-74.31%
3 Month Return-0.51%
1 Year Return-49.34%
5 Year Return-79.29%
Balaxi Pharmaceuticals Ltd Fundamentals
ROCE(TTM)5.78%
P/E Ratio (TTM)34.39
P/B Ratio0.96
Debt to Equity0.27
ROE3.87%
EPS (TTM)0.67
Dividend Yield0.00%
Book Value24.09
Profit Margin4.64%
Operating Margin-2.45%
Balaxi Pharmaceuticals Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 90.52 | 66.36 | 72.60 | 114.74 | 104.04 |
| EBITDA | 10.43 | 7.81 | 7.63 | 23.43 | 20.01 |
| Net Profit | 5.15 | 3.60 | 3.65 | 16.22 | 14.67 |
| EPS | 0.93 | 0.65 | 3.55 | 16.17 | 14.67 |
Balaxi Pharmaceuticals Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 22.44 |
| Resistance 1 (R1) | 24.27 |
| Pivot Point | 23.39 |
Balaxi Pharmaceuticals Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 01-Jul-2022 | 23-May-2022 | 04-Jul-2022 | Final | ₹0.50 |
BALAXI Key Leadership Details
Last Updated: Mar 2024
| Name | Position |
|---|---|
| Ashish Maheshwari | Managing Director |
| Minoshi Maheshwari | Non Executive Director |
| Kunal M Bhakta | Non Executive Independent Director |
Balaxi Pharmaceuticals Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,867.30+0.74% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,323.00+1.80% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,875.00+1.30% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Balaxi Pharmaceuticals Ltd today is ₹23.04 on NSE and ₹23.04 on BSE.
- The 52-week high of Balaxi Pharmaceuticals Ltd is ₹47.71, while the 52-week low is ₹15.20.
- The current market capitalisation of Balaxi Pharmaceuticals Ltd is approximately ₹127 crore.
- The P/E (Price-to-Earnings) ratio of Balaxi Pharmaceuticals Ltd is 10.60. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Balaxi Pharmaceuticals Ltd is 0.42. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Balaxi Pharmaceuticals Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BALAXI on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Balaxi Pharmaceuticals Ltd has delivered a return of approximately -74.31%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Balaxi Pharmaceuticals Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 65.99% promoters, 0.00% FIIs, 2.56% DIIs, and 24.43% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
